Gene Symbol | Gene ID | Gene Info |
---|---|---|
Plag1
|
ENSMUSG00000003282.3 | Plag1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Plag1 | chr4_3936566_3936717 | 1741 | 0.253748 | 0.33 | 1.1e-02 | Click! |
Plag1 | chr4_3937146_3938329 | 645 | 0.536094 | -0.29 | 2.6e-02 | Click! |
Plag1 | chr4_3934658_3934809 | 3649 | 0.167590 | 0.20 | 1.3e-01 | Click! |
Plag1 | chr4_3929394_3930248 | 8561 | 0.139618 | -0.18 | 1.8e-01 | Click! |
Plag1 | chr4_3929148_3929299 | 9159 | 0.138456 | -0.10 | 4.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_75148315_75152589 | 11.71 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr2_18042311_18043883 | 10.93 |
Skida1 |
SKI/DACH domain containing 1 |
1475 |
0.25 |
chr8_94994139_94995207 | 9.81 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
77 |
0.95 |
chr4_139831258_139832220 | 9.16 |
Pax7 |
paired box 7 |
1268 |
0.51 |
chr15_98003545_98005314 | 9.03 |
Col2a1 |
collagen, type II, alpha 1 |
62 |
0.97 |
chr5_116590520_116593206 | 8.60 |
Srrm4 |
serine/arginine repetitive matrix 4 |
46 |
0.98 |
chr7_19175632_19177533 | 8.59 |
Eml2 |
echinoderm microtubule associated protein like 2 |
161 |
0.88 |
chr8_121118797_121121438 | 8.58 |
Foxc2 |
forkhead box C2 |
3946 |
0.14 |
chr7_79498955_79500626 | 8.54 |
Mir9-3hg |
Mir9-3 host gene |
236 |
0.84 |
chr2_74725879_74728683 | 8.52 |
Hoxd4 |
homeobox D4 |
207 |
0.67 |
chr15_98989928_98991865 | 8.45 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
5002 |
0.1 |
chr8_70119024_70120981 | 8.08 |
Ncan |
neurocan |
871 |
0.35 |
chr1_19213854_19215338 | 7.98 |
Tfap2b |
transcription factor AP-2 beta |
717 |
0.69 |
chr14_67236008_67239452 | 7.69 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr15_83723881_83724305 | 7.63 |
Scube1 |
signal peptide, CUB domain, EGF-like 1 |
833 |
0.67 |
chr15_76519928_76521866 | 7.57 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chrX_143930842_143933141 | 7.56 |
Dcx |
doublecortin |
1059 |
0.64 |
chr15_100871055_100872065 | 7.38 |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
140 |
0.96 |
chr19_6418703_6419936 | 7.36 |
Nrxn2 |
neurexin II |
554 |
0.44 |
chr13_83732205_83734272 | 7.33 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr19_45230983_45235468 | 7.25 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr2_105680581_105683424 | 7.12 |
Pax6 |
paired box 6 |
290 |
0.89 |
chr11_96347886_96350398 | 6.98 |
Hoxb3os |
homeobox B3 and homeobox B2, opposite strand |
1219 |
0.21 |
chr5_120433178_120434996 | 6.86 |
Gm27199 |
predicted gene 27199 |
2320 |
0.19 |
chr3_87947557_87949450 | 6.75 |
Crabp2 |
cellular retinoic acid binding protein II |
163 |
0.9 |
chr15_102965066_102967702 | 6.72 |
Hoxc10 |
homeobox C10 |
412 |
0.6 |
chr11_97573801_97574201 | 6.70 |
Srcin1 |
SRC kinase signaling inhibitor 1 |
46 |
0.96 |
chr3_94478073_94479450 | 6.58 |
Celf3 |
CUGBP, Elav-like family member 3 |
70 |
0.92 |
chr4_139832357_139834219 | 6.48 |
Pax7 |
paired box 7 |
240 |
0.94 |
chr18_59062200_59063436 | 6.34 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
307 |
0.94 |
chrX_170674573_170675954 | 6.32 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr12_75176309_75177605 | 6.22 |
Kcnh5 |
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
375 |
0.92 |
chr17_55986138_55987186 | 6.16 |
Fsd1 |
fibronectin type 3 and SPRY domain-containing protein |
147 |
0.89 |
chr2_74734325_74737080 | 6.16 |
Hoxd3 |
homeobox D3 |
813 |
0.31 |
chr19_55746711_55749175 | 6.07 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
5098 |
0.32 |
chr7_43489310_43490670 | 6.06 |
Iglon5 |
IgLON family member 5 |
85 |
0.92 |
chr6_90781027_90782541 | 6.04 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
188 |
0.94 |
chr1_6729327_6730832 | 6.02 |
St18 |
suppression of tumorigenicity 18 |
9 |
0.99 |
chr11_41999400_42000640 | 6.01 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
336 |
0.92 |
chr1_172484027_172485046 | 5.98 |
Igsf9 |
immunoglobulin superfamily, member 9 |
2222 |
0.17 |
chr15_102981032_102982455 | 5.92 |
Hoxc9 |
homeobox C9 |
4711 |
0.09 |
chr9_106456260_106457377 | 5.92 |
Pcbp4 |
poly(rC) binding protein 4 |
721 |
0.42 |
chr1_132541040_132543287 | 5.85 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr2_29845262_29846623 | 5.84 |
Mir219a-2 |
microRNA 219a-2 |
215 |
0.56 |
chr2_172549301_172551909 | 5.79 |
Tfap2c |
transcription factor AP-2, gamma |
48 |
0.98 |
chr5_115431565_115432258 | 5.77 |
Msi1 |
musashi RNA-binding protein 1 |
1306 |
0.22 |
chr1_166255711_166256817 | 5.74 |
Ildr2 |
immunoglobulin-like domain containing receptor 2 |
2071 |
0.3 |
chr2_33629896_33632414 | 5.72 |
Lmx1b |
LIM homeobox transcription factor 1 beta |
1128 |
0.43 |
chr1_42686011_42687379 | 5.69 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
6398 |
0.14 |
chr7_79505833_79506958 | 5.68 |
Mir9-3 |
microRNA 9-3 |
1131 |
0.28 |
chr9_58197310_58202560 | 5.65 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr14_28508967_28511864 | 5.64 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
203 |
0.89 |
chr1_19215607_19218714 | 5.64 |
Tfap2b |
transcription factor AP-2 beta |
3281 |
0.25 |
chr17_93201490_93204144 | 5.60 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
741 |
0.65 |
chr4_150651111_150652374 | 5.60 |
Slc45a1 |
solute carrier family 45, member 1 |
355 |
0.88 |
chr2_109677166_109678631 | 5.58 |
Bdnf |
brain derived neurotrophic factor |
866 |
0.48 |
chr9_91363064_91363717 | 5.57 |
Zic1 |
zinc finger protein of the cerebellum 1 |
336 |
0.72 |
chr11_32001099_32002296 | 5.50 |
Nsg2 |
neuron specific gene family member 2 |
1195 |
0.52 |
chr2_178141581_178143125 | 5.49 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr11_108926426_108927821 | 5.48 |
Axin2 |
axin 2 |
3942 |
0.24 |
chr11_112784278_112785462 | 5.45 |
Sox9 |
SRY (sex determining region Y)-box 9 |
2646 |
0.24 |
chr17_47989917_47990574 | 5.44 |
Gm14871 |
predicted gene 14871 |
13327 |
0.14 |
chr15_95527528_95528774 | 5.44 |
Nell2 |
NEL-like 2 |
27 |
0.99 |
chr1_173366699_173367980 | 5.41 |
Cadm3 |
cell adhesion molecule 3 |
294 |
0.89 |
chr4_139823488_139824958 | 5.34 |
Pax7 |
paired box 7 |
8784 |
0.23 |
chrX_150656320_150657724 | 5.32 |
Tro |
trophinin |
350 |
0.85 |
chr2_9882196_9886301 | 5.32 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr10_109010138_109010322 | 5.31 |
Syt1 |
synaptotagmin I |
732 |
0.77 |
chr10_12614437_12615357 | 5.29 |
Utrn |
utrophin |
66 |
0.99 |
chr6_30737706_30740349 | 5.28 |
Mest |
mesoderm specific transcript |
972 |
0.4 |
chr10_103026340_103027824 | 5.24 |
Alx1 |
ALX homeobox 1 |
1545 |
0.39 |
chr19_44758783_44762005 | 5.18 |
Pax2 |
paired box 2 |
479 |
0.75 |
chr2_180890379_180892235 | 5.15 |
Gm14342 |
predicted gene 14342 |
1647 |
0.19 |
chr14_79768163_79769199 | 5.15 |
Gm9748 |
predicted gene 9748 |
1227 |
0.37 |
chr3_158559356_158560580 | 5.13 |
Lrrc7 |
leucine rich repeat containing 7 |
1368 |
0.57 |
chr16_5884597_5886147 | 5.10 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr1_180432613_180433627 | 5.10 |
Stum |
mechanosensory transduction mediator |
29492 |
0.12 |
chr1_172016118_172017482 | 5.09 |
Vangl2 |
VANGL planar cell polarity 2 |
7771 |
0.14 |
chr5_37248332_37249378 | 5.08 |
Crmp1 |
collapsin response mediator protein 1 |
1570 |
0.39 |
chr1_177446374_177448525 | 5.08 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
1628 |
0.31 |
chr17_93198991_93201483 | 5.07 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr1_136228373_136230942 | 5.03 |
Inava |
innate immunity activator |
362 |
0.76 |
chr9_35424475_35426234 | 4.91 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
1766 |
0.31 |
chr3_34654574_34655689 | 4.89 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
905 |
0.42 |
chr5_139546076_139547826 | 4.88 |
Uncx |
UNC homeobox |
3053 |
0.23 |
chr11_59288758_59290192 | 4.88 |
Wnt3a |
wingless-type MMTV integration site family, member 3A |
1277 |
0.33 |
chr19_4711641_4712943 | 4.87 |
Sptbn2 |
spectrin beta, non-erythrocytic 2 |
92 |
0.94 |
chr15_103026302_103028215 | 4.87 |
Hoxc4 |
homeobox C4 |
7137 |
0.09 |
chr14_122459815_122460898 | 4.85 |
Zic5 |
zinc finger protein of the cerebellum 5 |
335 |
0.81 |
chr10_116017652_116019652 | 4.84 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
365 |
0.92 |
chr1_63309029_63310075 | 4.83 |
Gm23448 |
predicted gene, 23448 |
9169 |
0.12 |
chr10_125968936_125969705 | 4.79 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
3067 |
0.37 |
chr6_90809120_90810568 | 4.79 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
279 |
0.89 |
chr12_118842631_118843755 | 4.75 |
Sp8 |
trans-acting transcription factor 8 |
3136 |
0.28 |
chr11_81611933_81613426 | 4.75 |
Gm11418 |
predicted gene 11418 |
25318 |
0.22 |
chr2_74713881_74716227 | 4.73 |
Hoxd3os1 |
homeobox D3, opposite strand 1 |
942 |
0.23 |
chr3_34648572_34651394 | 4.73 |
Sox2 |
SRY (sex determining region Y)-box 2 |
422 |
0.73 |
chr11_97499926_97501235 | 4.71 |
4933428G20Rik |
RIKEN cDNA 4933428G20 gene |
240 |
0.89 |
chr6_52245764_52247193 | 4.71 |
Hoxa11os |
homeobox A11, opposite strand |
257 |
0.65 |
chr5_37818003_37820431 | 4.71 |
Msx1 |
msh homeobox 1 |
5365 |
0.21 |
chr13_53469792_53470715 | 4.71 |
Msx2 |
msh homeobox 2 |
2821 |
0.27 |
chr7_3332929_3333897 | 4.70 |
Cacng7 |
calcium channel, voltage-dependent, gamma subunit 7 |
458 |
0.64 |
chr2_152080491_152081480 | 4.70 |
Scrt2 |
scratch family zinc finger 2 |
544 |
0.7 |
chr2_31638722_31641540 | 4.68 |
Prdm12 |
PR domain containing 12 |
94 |
0.84 |
chr17_45566052_45567713 | 4.66 |
Slc35b2 |
solute carrier family 35, member B2 |
2143 |
0.15 |
chr3_8509825_8511666 | 4.65 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr5_36868663_36870303 | 4.64 |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
820 |
0.55 |
chr1_75263860_75264397 | 4.64 |
Ptprn |
protein tyrosine phosphatase, receptor type, N |
78 |
0.92 |
chr4_141295756_141296471 | 4.63 |
Epha2 |
Eph receptor A2 |
5127 |
0.12 |
chr7_137316207_137318442 | 4.62 |
Ebf3 |
early B cell factor 3 |
2879 |
0.26 |
chr14_12343518_12345314 | 4.59 |
Fezf2 |
Fez family zinc finger 2 |
1428 |
0.3 |
chr15_25754177_25754669 | 4.59 |
Myo10 |
myosin X |
1444 |
0.48 |
chr4_140245362_140247262 | 4.59 |
Igsf21 |
immunoglobulin superfamily, member 21 |
472 |
0.85 |
chr2_116068937_116070512 | 4.58 |
G630016G05Rik |
RIKEN cDNA G630016G05 gene |
1756 |
0.28 |
chr11_120706268_120707653 | 4.58 |
Aspscr1 |
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
1698 |
0.13 |
chr8_121300864_121302289 | 4.58 |
Gm26815 |
predicted gene, 26815 |
55260 |
0.11 |
chr10_81472751_81473777 | 4.56 |
Celf5 |
CUGBP, Elav-like family member 5 |
114 |
0.9 |
chr6_52309839_52312950 | 4.56 |
Evx1 |
even-skipped homeobox 1 |
2104 |
0.14 |
chr4_126465012_126466992 | 4.54 |
Ago1 |
argonaute RISC catalytic subunit 1 |
2419 |
0.18 |
chr9_106147912_106149765 | 4.52 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
151 |
0.9 |
chr8_94995272_94995731 | 4.51 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
160 |
0.93 |
chr13_53470763_53471237 | 4.51 |
Msx2 |
msh homeobox 2 |
2074 |
0.32 |
chr7_45785390_45787192 | 4.48 |
Lmtk3 |
lemur tyrosine kinase 3 |
266 |
0.77 |
chr4_22494486_22495706 | 4.48 |
Gm30731 |
predicted gene, 30731 |
4548 |
0.18 |
chr11_108927950_108929274 | 4.47 |
Axin2 |
axin 2 |
5431 |
0.22 |
chr7_64501626_64502920 | 4.45 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
135 |
0.96 |
chr11_22006485_22009037 | 4.44 |
Otx1 |
orthodenticle homeobox 1 |
4864 |
0.28 |
chr7_79507205_79507895 | 4.44 |
Mir9-3 |
microRNA 9-3 |
2286 |
0.14 |
chr3_55782570_55784448 | 4.43 |
Nbea |
neurobeachin |
19 |
0.96 |
chrX_105390628_105392456 | 4.39 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr1_24195123_24196359 | 4.39 |
Col9a1 |
collagen, type IX, alpha 1 |
554 |
0.82 |
chr5_115438447_115439259 | 4.39 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
2209 |
0.13 |
chr2_33641457_33645822 | 4.38 |
C130021I20Rik |
Riken cDNA C130021I20 gene |
2308 |
0.22 |
chrX_143518219_143519318 | 4.38 |
Pak3 |
p21 (RAC1) activated kinase 3 |
70 |
0.98 |
chr16_77236731_77239778 | 4.37 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
1935 |
0.4 |
chr9_69763544_69764965 | 4.35 |
B230323A14Rik |
RIKEN cDNA B230323A14 gene |
3108 |
0.23 |
chr5_139550965_139553757 | 4.35 |
Uncx |
UNC homeobox |
8463 |
0.18 |
chr7_144283851_144285174 | 4.33 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
33 |
0.99 |
chr17_12636042_12637507 | 4.33 |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
15934 |
0.17 |
chr8_108699179_108700683 | 4.33 |
Zfhx3 |
zinc finger homeobox 3 |
3169 |
0.32 |
chr11_55607331_55608633 | 4.32 |
Glra1 |
glycine receptor, alpha 1 subunit |
161 |
0.96 |
chr14_119123052_119124306 | 4.31 |
Hs6st3 |
heparan sulfate 6-O-sulfotransferase 3 |
14662 |
0.18 |
chr13_83719687_83720586 | 4.30 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1245 |
0.36 |
chr3_89226055_89227441 | 4.29 |
Mtx1 |
metaxin 1 |
304 |
0.42 |
chr12_27336880_27337279 | 4.29 |
Sox11 |
SRY (sex determining region Y)-box 11 |
5495 |
0.31 |
chr7_70347472_70349327 | 4.28 |
Gm44948 |
predicted gene 44948 |
703 |
0.54 |
chr12_117153278_117156362 | 4.28 |
Gm10421 |
predicted gene 10421 |
3169 |
0.37 |
chr1_72826047_72827238 | 4.28 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
1320 |
0.5 |
chr11_85833878_85836704 | 4.28 |
Tbx2 |
T-box 2 |
2740 |
0.17 |
chr10_57784547_57786586 | 4.27 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr8_87469746_87471270 | 4.27 |
Cbln1 |
cerebellin 1 precursor protein |
560 |
0.63 |
chr2_151969889_151971485 | 4.26 |
Fam110a |
family with sequence similarity 110, member A |
2707 |
0.18 |
chr4_91374442_91375761 | 4.25 |
Elavl2 |
ELAV like RNA binding protein 1 |
1206 |
0.41 |
chr11_103775036_103776082 | 4.24 |
Wnt3 |
wingless-type MMTV integration site family, member 3 |
1409 |
0.37 |
chr8_123413418_123414506 | 4.24 |
Tubb3 |
tubulin, beta 3 class III |
2372 |
0.11 |
chr1_42693836_42695485 | 4.22 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
148 |
0.5 |
chr15_85580567_85581814 | 4.22 |
AU022754 |
expressed sequence AU022754 |
48 |
0.86 |
chr4_154635108_154637998 | 4.22 |
Prdm16 |
PR domain containing 16 |
244 |
0.83 |
chr7_45366021_45366296 | 4.21 |
Mtag2 |
metastasis associated gene 2 |
5 |
0.86 |
chr13_83721518_83722206 | 4.19 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
481 |
0.73 |
chr3_5220585_5221267 | 4.18 |
2700069I18Rik |
RIKEN cDNA 2700069I18 gene |
85 |
0.9 |
chr13_55835316_55837389 | 4.18 |
Pitx1 |
paired-like homeodomain transcription factor 1 |
160 |
0.62 |
chr10_99267189_99269284 | 4.18 |
Gm48089 |
predicted gene, 48089 |
340 |
0.78 |
chr9_58128949_58130350 | 4.16 |
Stra6 |
stimulated by retinoic acid gene 6 |
148 |
0.93 |
chr13_55825087_55826711 | 4.15 |
Gm47071 |
predicted gene, 47071 |
351 |
0.82 |
chr3_34652462_34653573 | 4.14 |
Sox2 |
SRY (sex determining region Y)-box 2 |
2612 |
0.16 |
chr8_94995811_94996872 | 4.09 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
680 |
0.57 |
chr1_42707054_42709031 | 4.09 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
10 |
0.97 |
chr4_125490136_125491914 | 4.07 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
325 |
0.89 |
chr2_10372882_10374693 | 4.06 |
Gm13261 |
predicted gene 13261 |
254 |
0.68 |
chr3_17793835_17795104 | 4.06 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
427 |
0.75 |
chr7_5056231_5057716 | 4.05 |
Gm15510 |
predicted gene 15510 |
53 |
0.48 |
chr2_136713069_136714459 | 4.05 |
Snap25 |
synaptosomal-associated protein 25 |
286 |
0.92 |
chr7_144898015_144898977 | 4.04 |
Gm26793 |
predicted gene, 26793 |
1035 |
0.34 |
chr1_42691569_42692627 | 4.04 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
995 |
0.42 |
chr1_42684511_42685482 | 4.04 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
8097 |
0.14 |
chr13_60173877_60174441 | 4.03 |
Gm48488 |
predicted gene, 48488 |
2523 |
0.23 |
chr11_69835948_69836218 | 4.02 |
Nlgn2 |
neuroligin 2 |
1234 |
0.17 |
chr7_44592789_44594513 | 4.02 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
344 |
0.69 |
chr12_29529828_29531185 | 4.01 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr8_23383936_23384937 | 4.01 |
Sfrp1 |
secreted frizzled-related protein 1 |
27066 |
0.19 |
chr15_74563319_74564610 | 4.00 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
63 |
0.61 |
chr3_88208231_88208654 | 3.98 |
Gm3764 |
predicted gene 3764 |
1030 |
0.28 |
chr7_54835204_54836499 | 3.98 |
Luzp2 |
leucine zipper protein 2 |
236 |
0.94 |
chr5_138271764_138273195 | 3.98 |
Gal3st4 |
galactose-3-O-sulfotransferase 4 |
270 |
0.76 |
chr15_85576096_85578271 | 3.97 |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
887 |
0.54 |
chr1_138839332_138840406 | 3.95 |
Lhx9 |
LIM homeobox protein 9 |
2560 |
0.22 |
chr2_70561988_70564432 | 3.94 |
Gad1os |
glutamate decarboxylase 1, opposite strand |
147 |
0.61 |
chr1_78189316_78190249 | 3.93 |
Pax3 |
paired box 3 |
7056 |
0.24 |
chr11_69558887_69560206 | 3.93 |
Efnb3 |
ephrin B3 |
659 |
0.46 |
chr11_120238467_120239478 | 3.93 |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
2273 |
0.16 |
chr17_72602980_72604745 | 3.92 |
Alk |
anaplastic lymphoma kinase |
35 |
0.99 |
chr6_110645148_110646464 | 3.92 |
Gm20387 |
predicted gene 20387 |
110 |
0.67 |
chr9_22050521_22051976 | 3.92 |
Elavl3 |
ELAV like RNA binding protein 3 |
762 |
0.41 |
chr11_21995570_21998947 | 3.92 |
Otx1 |
orthodenticle homeobox 1 |
4357 |
0.28 |
chr5_128599084_128599753 | 3.92 |
Fzd10os |
frizzled class receptor 10, opposite strand |
1236 |
0.28 |
chr13_69737356_69737994 | 3.91 |
Ube2ql1 |
ubiquitin-conjugating enzyme E2Q family-like 1 |
2214 |
0.21 |
chr10_90828879_90830154 | 3.90 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
50 |
0.97 |
chr6_93911862_93913573 | 3.88 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr3_66977838_66980287 | 3.87 |
Shox2 |
short stature homeobox 2 |
251 |
0.9 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.4 | 19.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
6.3 | 25.0 | GO:0061205 | paramesonephric duct development(GO:0061205) |
5.0 | 14.9 | GO:0061642 | chemoattraction of axon(GO:0061642) |
4.8 | 4.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
4.5 | 22.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
4.4 | 13.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
4.2 | 12.6 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
4.2 | 8.4 | GO:0061551 | trigeminal ganglion development(GO:0061551) |
4.1 | 4.1 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
4.0 | 8.0 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
3.9 | 15.8 | GO:0060594 | mammary gland specification(GO:0060594) |
3.9 | 7.8 | GO:0070384 | Harderian gland development(GO:0070384) |
3.8 | 11.3 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
3.8 | 11.3 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
3.8 | 11.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
3.6 | 14.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
3.3 | 19.7 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
3.3 | 26.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
3.1 | 6.2 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
3.1 | 12.4 | GO:0007412 | axon target recognition(GO:0007412) |
3.1 | 3.1 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
3.0 | 38.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
3.0 | 8.9 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
2.9 | 8.8 | GO:0072017 | distal tubule development(GO:0072017) |
2.8 | 8.5 | GO:0002930 | trabecular meshwork development(GO:0002930) |
2.8 | 8.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.8 | 13.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.7 | 8.2 | GO:0014016 | neuroblast differentiation(GO:0014016) |
2.7 | 10.8 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
2.7 | 8.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
2.7 | 21.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
2.7 | 2.7 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
2.6 | 10.4 | GO:0061743 | motor learning(GO:0061743) |
2.6 | 12.8 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
2.4 | 2.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
2.4 | 9.6 | GO:0048625 | myoblast fate commitment(GO:0048625) |
2.3 | 7.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
2.3 | 18.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.2 | 6.6 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
2.2 | 4.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.2 | 6.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
2.1 | 23.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.1 | 10.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
2.1 | 4.1 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
2.1 | 6.2 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
2.0 | 8.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.0 | 3.9 | GO:0060174 | limb bud formation(GO:0060174) |
1.9 | 5.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.9 | 5.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.9 | 5.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.9 | 1.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.9 | 1.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.9 | 9.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.8 | 1.8 | GO:0072033 | renal vesicle formation(GO:0072033) |
1.8 | 1.8 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.8 | 1.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.8 | 3.7 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.8 | 3.6 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.8 | 7.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.8 | 5.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.8 | 8.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.8 | 5.4 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.8 | 7.1 | GO:0030035 | microspike assembly(GO:0030035) |
1.7 | 7.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.7 | 15.7 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
1.7 | 1.7 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
1.7 | 6.9 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
1.7 | 5.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.7 | 20.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.7 | 5.1 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
1.7 | 5.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.7 | 5.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.7 | 5.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.7 | 5.0 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.7 | 5.0 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
1.6 | 4.9 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
1.6 | 19.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.6 | 4.8 | GO:0021586 | pons maturation(GO:0021586) |
1.6 | 4.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.6 | 1.6 | GO:0010159 | specification of organ position(GO:0010159) |
1.6 | 3.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.6 | 4.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.6 | 3.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.6 | 6.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.6 | 9.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.5 | 12.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.5 | 6.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.5 | 1.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.5 | 6.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.5 | 4.5 | GO:0048619 | hindgut morphogenesis(GO:0007442) embryonic hindgut morphogenesis(GO:0048619) |
1.5 | 3.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.5 | 5.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.5 | 11.7 | GO:0071625 | vocalization behavior(GO:0071625) |
1.4 | 4.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.4 | 2.9 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.4 | 1.4 | GO:0035799 | ureter maturation(GO:0035799) |
1.4 | 1.4 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.4 | 1.4 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.4 | 1.4 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
1.4 | 19.6 | GO:0003417 | growth plate cartilage development(GO:0003417) |
1.4 | 2.8 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.4 | 34.6 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
1.4 | 2.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.4 | 2.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.4 | 4.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.4 | 4.1 | GO:0097503 | sialylation(GO:0097503) |
1.3 | 5.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
1.3 | 4.0 | GO:0033058 | directional locomotion(GO:0033058) |
1.3 | 5.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.3 | 1.3 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.3 | 1.3 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
1.3 | 6.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.3 | 2.6 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.3 | 18.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.3 | 9.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.3 | 1.3 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
1.3 | 5.1 | GO:0021854 | hypothalamus development(GO:0021854) |
1.3 | 5.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.3 | 5.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
1.3 | 2.5 | GO:0021550 | medulla oblongata development(GO:0021550) |
1.3 | 2.5 | GO:0060596 | mammary placode formation(GO:0060596) |
1.2 | 8.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.2 | 2.5 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
1.2 | 2.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.2 | 3.7 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.2 | 3.6 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.2 | 2.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.2 | 1.2 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
1.2 | 7.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.2 | 2.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.2 | 7.1 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.2 | 5.9 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
1.2 | 3.5 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.2 | 7.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
1.2 | 3.5 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.2 | 2.3 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.2 | 1.2 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
1.1 | 60.9 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
1.1 | 9.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.1 | 3.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.1 | 5.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.1 | 4.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.1 | 23.6 | GO:0001964 | startle response(GO:0001964) |
1.1 | 1.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.1 | 5.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.1 | 3.3 | GO:0048840 | otolith development(GO:0048840) |
1.1 | 1.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.1 | 1.1 | GO:1905214 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
1.1 | 2.2 | GO:0060166 | olfactory pit development(GO:0060166) |
1.1 | 3.3 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.1 | 1.1 | GO:0021557 | oculomotor nerve development(GO:0021557) |
1.1 | 56.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.1 | 33.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
1.1 | 2.1 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
1.1 | 13.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.1 | 5.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
1.0 | 11.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.0 | 2.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.0 | 1.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.0 | 11.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
1.0 | 3.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
1.0 | 4.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.0 | 6.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
1.0 | 4.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.0 | 5.0 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.0 | 4.0 | GO:0010288 | response to lead ion(GO:0010288) |
1.0 | 1.0 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
1.0 | 2.0 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
1.0 | 1.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
1.0 | 5.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.0 | 2.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.0 | 1.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.9 | 2.8 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.9 | 8.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.9 | 1.9 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.9 | 2.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.9 | 3.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.9 | 2.8 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.9 | 1.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.9 | 1.9 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.9 | 2.8 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.9 | 0.9 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.9 | 9.1 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.9 | 1.8 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.9 | 1.8 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.9 | 2.7 | GO:0060023 | soft palate development(GO:0060023) |
0.9 | 1.8 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.9 | 6.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.9 | 1.8 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.9 | 2.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.9 | 0.9 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.9 | 3.5 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.9 | 0.9 | GO:0015744 | succinate transport(GO:0015744) |
0.9 | 2.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.9 | 0.9 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.9 | 5.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.9 | 0.9 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.9 | 1.7 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.8 | 10.9 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.8 | 8.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.8 | 22.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.8 | 2.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.8 | 5.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.8 | 0.8 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.8 | 2.5 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.8 | 7.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.8 | 0.8 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.8 | 1.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.8 | 8.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.8 | 1.6 | GO:1902075 | cellular response to salt(GO:1902075) |
0.8 | 1.6 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.8 | 3.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.8 | 8.7 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.8 | 0.8 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.8 | 4.7 | GO:0030903 | notochord development(GO:0030903) |
0.8 | 0.8 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.8 | 0.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.8 | 3.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.8 | 1.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.8 | 3.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.8 | 0.8 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.8 | 1.5 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.8 | 2.3 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.8 | 1.5 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.8 | 2.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.8 | 5.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.8 | 6.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.8 | 0.8 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.8 | 2.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.7 | 0.7 | GO:0061055 | myotome development(GO:0061055) |
0.7 | 12.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.7 | 1.5 | GO:0001757 | somite specification(GO:0001757) |
0.7 | 1.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.7 | 2.9 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.7 | 1.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.7 | 2.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.7 | 1.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.7 | 0.7 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.7 | 1.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.7 | 1.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.7 | 2.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.7 | 2.8 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.7 | 2.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.7 | 1.4 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.7 | 2.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.7 | 2.8 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.7 | 2.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.7 | 2.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.7 | 5.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.7 | 1.4 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.7 | 2.0 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.7 | 2.0 | GO:0015817 | histidine transport(GO:0015817) |
0.7 | 2.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.7 | 2.0 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.7 | 1.3 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.7 | 2.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.7 | 14.1 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.7 | 2.0 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.7 | 2.0 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.7 | 2.0 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.7 | 2.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 1.3 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.7 | 1.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 1.3 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) regulation of eosinophil activation(GO:1902566) |
0.7 | 2.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.7 | 1.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.6 | 3.9 | GO:0008038 | neuron recognition(GO:0008038) |
0.6 | 4.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.6 | 46.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 0.6 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.6 | 1.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.6 | 7.0 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.6 | 1.9 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.6 | 1.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.6 | 0.6 | GO:1904398 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) positive regulation of neuromuscular junction development(GO:1904398) |
0.6 | 0.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.6 | 1.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.6 | 1.2 | GO:0046959 | habituation(GO:0046959) |
0.6 | 1.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.6 | 1.8 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.6 | 1.2 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.6 | 1.8 | GO:0015747 | urate transport(GO:0015747) |
0.6 | 1.8 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.6 | 3.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.6 | 0.6 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.6 | 1.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.6 | 5.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.6 | 7.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.6 | 2.9 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.6 | 0.6 | GO:0048489 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
0.6 | 1.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.6 | 1.1 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.6 | 1.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.6 | 3.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 1.7 | GO:0033504 | floor plate development(GO:0033504) |
0.6 | 2.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.6 | 0.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.6 | 0.6 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.6 | 3.3 | GO:0045176 | apical protein localization(GO:0045176) |
0.6 | 5.0 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.6 | 1.7 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.6 | 1.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.5 | 2.7 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.5 | 1.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.5 | 1.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.5 | 7.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 1.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.5 | 0.5 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.5 | 1.6 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.5 | 1.1 | GO:0099612 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.5 | 1.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.5 | 3.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.5 | 0.5 | GO:0052042 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.5 | 1.0 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.5 | 1.5 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.5 | 0.5 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.5 | 0.5 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.5 | 1.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.5 | 8.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.5 | 1.0 | GO:0048664 | neuron fate determination(GO:0048664) |
0.5 | 1.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.5 | 2.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.5 | 1.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.5 | 1.5 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.5 | 10.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.5 | 1.4 | GO:0070305 | response to cGMP(GO:0070305) |
0.5 | 2.4 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.5 | 0.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.5 | 1.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.5 | 6.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.5 | 1.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.5 | 1.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.5 | 1.4 | GO:0001975 | response to amphetamine(GO:0001975) |
0.5 | 0.9 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.5 | 3.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.5 | 4.2 | GO:0035640 | exploration behavior(GO:0035640) |
0.5 | 3.7 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.5 | 1.8 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.5 | 0.5 | GO:0071599 | otic vesicle development(GO:0071599) |
0.5 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.5 | 1.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.5 | 1.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.5 | 1.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.5 | 1.4 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.5 | 0.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.5 | 0.5 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.4 | 1.8 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.4 | 0.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.4 | 0.9 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 0.4 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.4 | 1.8 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.4 | 1.8 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.4 | 1.3 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 3.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 2.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.4 | 0.4 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.4 | 4.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 2.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 1.3 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.4 | 1.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 1.3 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.4 | 1.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.4 | 3.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 0.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.4 | 8.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.4 | 1.6 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 1.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.4 | 0.4 | GO:0046958 | nonassociative learning(GO:0046958) |
0.4 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 7.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.4 | 2.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.4 | 1.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.4 | 1.2 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.4 | 0.8 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 1.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.4 | 1.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.4 | 6.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.4 | 2.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 1.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 0.4 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.4 | 3.9 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.4 | 2.3 | GO:0007614 | short-term memory(GO:0007614) |
0.4 | 4.6 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.4 | 1.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.4 | 0.4 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.4 | 2.7 | GO:0060914 | heart formation(GO:0060914) |
0.4 | 0.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.4 | 1.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.4 | 1.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.4 | 1.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 1.9 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.4 | 0.7 | GO:0051593 | response to folic acid(GO:0051593) |
0.4 | 0.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.4 | 4.8 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.4 | 0.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.4 | 1.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.4 | 1.1 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.4 | 1.5 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.4 | 0.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 2.9 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.4 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.4 | 1.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 1.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 1.1 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
0.3 | 8.4 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.3 | 0.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 3.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.3 | 1.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 1.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 0.3 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.3 | 18.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 2.7 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.3 | 1.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 | 0.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 0.7 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 0.7 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.3 | 1.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 4.3 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 0.7 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.3 | 3.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.3 | 2.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.3 | 1.0 | GO:0032202 | telomere assembly(GO:0032202) |
0.3 | 3.2 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.3 | 0.6 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.3 | 0.6 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.3 | 1.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.3 | 0.6 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.3 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 7.6 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.3 | 0.6 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.3 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.3 | 0.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 1.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 1.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 0.3 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.3 | 5.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.3 | 3.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 0.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.3 | 0.6 | GO:0008355 | olfactory learning(GO:0008355) |
0.3 | 3.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.3 | 5.2 | GO:0002209 | behavioral defense response(GO:0002209) |
0.3 | 1.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 0.9 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 1.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 0.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 3.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 1.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 0.6 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 0.9 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.3 | 2.6 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.3 | 0.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.3 | 0.6 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.3 | 7.9 | GO:0008542 | visual learning(GO:0008542) |
0.3 | 0.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.3 | 0.8 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.3 | 0.6 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 0.8 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 0.5 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.3 | 20.2 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.3 | 2.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 1.3 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.3 | 0.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.3 | GO:0021988 | olfactory lobe development(GO:0021988) |
0.3 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 0.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 0.8 | GO:0050654 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.3 | 1.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 0.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.3 | 0.3 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.3 | 0.5 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.3 | 2.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 1.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 0.5 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.3 | 1.3 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.3 | 2.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 0.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.7 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.5 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 1.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.5 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 1.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.2 | 6.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 1.0 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 1.0 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.2 | 0.7 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 1.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 0.2 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 1.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 1.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.2 | 0.2 | GO:0021546 | rhombomere development(GO:0021546) |
0.2 | 1.5 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 0.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 3.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.6 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 1.9 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 0.2 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 1.9 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 2.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.6 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.6 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.2 | 0.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 2.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 1.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 0.6 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.2 | GO:0061525 | hindgut development(GO:0061525) |
0.2 | 1.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 1.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 0.4 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 1.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 0.8 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 0.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 0.4 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.2 | 0.6 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.2 | 0.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.2 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 2.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 2.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 0.4 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.2 | 1.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 1.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 0.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 0.7 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 0.5 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 0.9 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.2 | 0.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.5 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.2 | 1.1 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 0.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.2 | 1.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.2 | 0.7 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.3 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 1.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 0.3 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 2.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 1.0 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.2 | 0.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.2 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
0.2 | 0.6 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.2 | 0.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.5 | GO:0002063 | chondrocyte development(GO:0002063) |
0.2 | 0.9 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 1.4 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.2 | 0.6 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.2 | 0.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.2 | 0.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 0.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 0.2 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.2 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.8 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.2 | 2.0 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 | 0.3 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 1.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 4.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.4 | GO:0090656 | t-circle formation(GO:0090656) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.1 | 0.4 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 0.4 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.3 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.1 | 1.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.6 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.8 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 0.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 1.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 1.5 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 1.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 1.3 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 1.4 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.1 | 1.5 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 7.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 1.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.4 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.8 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.9 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.9 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 1.2 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.3 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.6 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.3 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.3 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.1 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.1 | 1.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.6 | GO:0035107 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.1 | 0.3 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.1 | 0.8 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 1.3 | GO:0060021 | palate development(GO:0060021) |
0.1 | 0.5 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.1 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 1.8 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 2.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) |
0.1 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.3 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.1 | 0.9 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.2 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.1 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
0.1 | 0.5 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.1 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.1 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.1 | 0.5 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.2 | GO:1903897 | regulation of PERK-mediated unfolded protein response(GO:1903897) |
0.1 | 0.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.7 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.3 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.1 | GO:1990314 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.1 | GO:2001169 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) regulation of ATP biosynthetic process(GO:2001169) negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 0.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.3 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.1 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.1 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.8 | GO:0060323 | head morphogenesis(GO:0060323) |
0.1 | 0.2 | GO:0015872 | dopamine transport(GO:0015872) |
0.1 | 0.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.1 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.1 | 0.2 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.3 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.3 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.1 | 0.2 | GO:0045006 | DNA deamination(GO:0045006) |
0.0 | 0.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.5 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.0 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.0 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.0 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 1.8 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.0 | 0.1 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.4 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.2 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.0 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
0.0 | 0.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.2 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.0 | 0.3 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.8 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.0 | 0.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.0 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.0 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.0 | 0.0 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.0 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.0 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.2 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.2 | 26.9 | GO:0043194 | axon initial segment(GO:0043194) |
2.0 | 6.1 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.0 | 8.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.0 | 2.0 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.9 | 23.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.8 | 5.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.8 | 12.5 | GO:0032584 | growth cone membrane(GO:0032584) |
1.7 | 16.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.6 | 19.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.6 | 4.7 | GO:0044393 | microspike(GO:0044393) |
1.6 | 18.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.5 | 7.7 | GO:0043083 | synaptic cleft(GO:0043083) |
1.5 | 9.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.5 | 28.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.5 | 1.5 | GO:0035838 | growing cell tip(GO:0035838) |
1.4 | 5.7 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.3 | 39.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.2 | 5.0 | GO:0071953 | elastic fiber(GO:0071953) |
1.2 | 3.7 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.2 | 4.9 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.2 | 3.6 | GO:0097427 | microtubule bundle(GO:0097427) |
1.2 | 4.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.2 | 3.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.2 | 1.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.1 | 9.9 | GO:0005883 | neurofilament(GO:0005883) |
1.1 | 2.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.1 | 25.4 | GO:0044295 | axonal growth cone(GO:0044295) |
1.0 | 8.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.0 | 3.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.0 | 3.1 | GO:0000322 | storage vacuole(GO:0000322) |
1.0 | 1.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.0 | 10.9 | GO:0035102 | PRC1 complex(GO:0035102) |
1.0 | 3.0 | GO:0072534 | perineuronal net(GO:0072534) |
1.0 | 43.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.9 | 21.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.8 | 4.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.8 | 7.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.8 | 10.9 | GO:0043196 | varicosity(GO:0043196) |
0.7 | 0.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.7 | 10.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.7 | 2.9 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.7 | 10.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.7 | 8.8 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.7 | 7.3 | GO:0031045 | dense core granule(GO:0031045) |
0.7 | 3.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.7 | 3.3 | GO:0043203 | axon hillock(GO:0043203) |
0.7 | 3.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.6 | 10.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.6 | 19.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.6 | 5.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.6 | 2.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.6 | 1.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.6 | 48.4 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 1.8 | GO:1990696 | USH2 complex(GO:1990696) |
0.6 | 1.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.6 | 14.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.6 | 67.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.6 | 0.6 | GO:0005687 | U4 snRNP(GO:0005687) |
0.6 | 2.8 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.6 | 1.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 3.9 | GO:0030673 | axolemma(GO:0030673) |
0.6 | 2.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.5 | 1.6 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 1.6 | GO:0008091 | spectrin(GO:0008091) |
0.5 | 2.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.5 | 4.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 5.9 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 1.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 2.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 4.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 0.9 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.5 | 3.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 0.9 | GO:0032437 | cuticular plate(GO:0032437) |
0.4 | 8.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 4.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 6.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.4 | 1.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 3.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 1.2 | GO:0097433 | dense body(GO:0097433) |
0.4 | 1.6 | GO:1990745 | EARP complex(GO:1990745) |
0.4 | 1.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 1.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.4 | 1.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 10.2 | GO:0016235 | aggresome(GO:0016235) |
0.4 | 1.9 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 7.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.4 | 2.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 1.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 16.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 3.5 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 3.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 1.7 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 0.3 | GO:0044298 | cell body membrane(GO:0044298) |
0.3 | 1.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 1.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 1.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 3.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 1.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 0.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 1.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 2.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 0.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 90.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 0.5 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 3.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 1.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 1.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 1.2 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 17.8 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 0.7 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 0.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 3.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 2.5 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.2 | 9.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 13.9 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 1.7 | GO:0098793 | presynapse(GO:0098793) |
0.2 | 28.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 3.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 0.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 0.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 8.1 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 4.0 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 0.8 | GO:0002177 | manchette(GO:0002177) |
0.2 | 1.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.5 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 19.2 | GO:0030424 | axon(GO:0030424) |
0.2 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.6 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 1.5 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.6 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.9 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 1.0 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 1.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 1.1 | GO:0036157 | axonemal dynein complex(GO:0005858) outer dynein arm(GO:0036157) |
0.1 | 1.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.5 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.3 | GO:0043205 | fibril(GO:0043205) |
0.1 | 1.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.4 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.1 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 1.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 1.1 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.3 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 7.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 2.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 2.2 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.3 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 10.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.5 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 1.7 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 1.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.2 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 20.0 | GO:0003680 | AT DNA binding(GO:0003680) |
2.9 | 14.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.8 | 2.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.8 | 8.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
2.5 | 7.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.4 | 21.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.3 | 7.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.2 | 29.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
2.1 | 12.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
2.1 | 6.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.0 | 6.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
2.0 | 5.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.9 | 9.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.8 | 11.0 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.7 | 7.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.6 | 14.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
1.6 | 4.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.6 | 4.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.5 | 32.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.5 | 20.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.5 | 6.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.5 | 7.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.5 | 5.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.5 | 4.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.4 | 5.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.4 | 18.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.4 | 6.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.4 | 5.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.3 | 3.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.3 | 15.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.3 | 7.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.3 | 1.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.2 | 2.5 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.2 | 24.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.2 | 3.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.2 | 8.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.2 | 4.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.2 | 3.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.1 | 5.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.1 | 3.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.1 | 6.7 | GO:0048495 | Roundabout binding(GO:0048495) |
1.1 | 3.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.1 | 4.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.1 | 1.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
1.1 | 8.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.1 | 5.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.0 | 5.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.0 | 8.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.0 | 4.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.0 | 3.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.0 | 2.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.0 | 1.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.0 | 5.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.0 | 18.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.0 | 3.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.0 | 3.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.0 | 4.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.0 | 3.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.0 | 2.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.0 | 6.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.0 | 2.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.0 | 16.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.9 | 10.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.9 | 2.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.9 | 2.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.9 | 2.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.9 | 0.9 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.9 | 4.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.8 | 8.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.8 | 11.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.8 | 2.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.8 | 2.4 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.8 | 3.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.8 | 3.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.8 | 12.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.7 | 10.5 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.7 | 0.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.7 | 3.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.7 | 2.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.7 | 4.3 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.7 | 3.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 2.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.7 | 3.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 4.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.7 | 2.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.7 | 3.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.7 | 2.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.7 | 4.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.7 | 3.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 2.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.7 | 3.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.7 | 8.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.7 | 15.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.6 | 3.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.6 | 17.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.6 | 5.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.6 | 4.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.6 | 18.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 3.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.6 | 1.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.6 | 1.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.6 | 2.9 | GO:0046790 | virion binding(GO:0046790) |
0.6 | 3.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.6 | 6.8 | GO:0031005 | filamin binding(GO:0031005) |
0.6 | 1.7 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.6 | 12.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 3.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.5 | 1.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 12.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.5 | 1.6 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.5 | 8.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 2.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 2.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 2.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.5 | 1.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.5 | 2.0 | GO:0097001 | ceramide binding(GO:0097001) |
0.5 | 5.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 3.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.5 | 1.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.5 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 3.4 | GO:0005272 | sodium channel activity(GO:0005272) |
0.5 | 14.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.5 | 1.4 | GO:0018561 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.5 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.5 | 0.9 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.5 | 0.9 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.5 | 8.7 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.5 | 2.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 3.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 1.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.5 | 4.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 0.9 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.5 | 1.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.4 | 0.9 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.4 | 1.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 1.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 1.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 1.7 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.4 | 4.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 0.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 14.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 3.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.4 | 5.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.4 | 0.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 0.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 0.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 1.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 1.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 1.2 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.4 | 4.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.4 | 0.4 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.4 | 0.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 3.5 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.4 | 2.3 | GO:0033265 | choline binding(GO:0033265) |
0.4 | 0.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 0.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.4 | 5.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.4 | 1.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 1.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 2.2 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 4.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 0.4 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.4 | 1.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 1.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 1.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.4 | 0.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 6.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 2.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 3.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 2.1 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.3 | 2.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 1.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 0.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 1.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 0.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 1.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 6.1 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.3 | 4.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 1.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 1.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 10.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 1.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 2.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 7.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 7.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.3 | 2.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 4.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 2.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 12.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.3 | 2.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 0.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 0.9 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 2.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 1.7 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 5.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 3.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 0.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.3 | 1.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 0.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 240.5 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.3 | 0.8 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 9.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 0.8 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.3 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 5.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 3.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 0.8 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 1.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 2.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 0.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 1.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 1.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 1.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 0.9 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 1.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.2 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.2 | 3.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 1.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 1.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 0.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 0.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 2.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.2 | 0.6 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 1.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 3.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 1.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 2.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.8 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 2.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 1.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.8 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 3.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 4.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 2.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 2.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.2 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 16.9 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 2.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.9 | GO:0060229 | lipase activator activity(GO:0060229) |
0.2 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 0.7 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 3.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 0.9 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.2 | 0.2 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.2 | 4.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 2.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 1.4 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.2 | 2.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.3 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 1.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 0.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 3.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.2 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.2 | 0.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.3 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 0.8 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 1.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.6 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 20.2 | GO:0003729 | mRNA binding(GO:0003729) |
0.2 | 0.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 1.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 1.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 2.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 3.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 1.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.1 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 1.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 1.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 3.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 2.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.3 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 10.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 1.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 2.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 1.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 1.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 6.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.7 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 1.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 3.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 3.1 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.0 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.6 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 1.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.5 | GO:0000907 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.0 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 6.4 | PID REELIN PATHWAY | Reelin signaling pathway |
1.3 | 35.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.0 | 14.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.7 | 29.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.6 | 2.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.6 | 18.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 16.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.5 | 7.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 10.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 8.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 8.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 19.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 0.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 1.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 5.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 4.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 1.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 3.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 13.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 5.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 3.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 10.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 6.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 33.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 6.2 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.2 | 1.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 3.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 2.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 4.9 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 10.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 14.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 1.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 21.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.6 | 1.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.4 | 20.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.4 | 19.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.3 | 25.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.2 | 17.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.2 | 45.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.0 | 10.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.0 | 20.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.9 | 10.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.9 | 29.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.9 | 8.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.9 | 15.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.8 | 16.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.8 | 3.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.8 | 8.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.7 | 7.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.7 | 2.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.6 | 26.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 11.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 5.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.6 | 47.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.6 | 7.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.5 | 1.6 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.4 | 1.8 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.4 | 11.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.4 | 0.4 | REACTOME HIV INFECTION | Genes involved in HIV Infection |
0.4 | 9.0 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.4 | 14.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 8.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 3.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 4.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 12.1 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.3 | 6.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 2.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.3 | 3.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.2 | 2.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 3.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 2.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 2.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 3.7 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 1.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 3.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 4.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 4.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 1.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 1.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 0.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 1.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 0.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 0.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 1.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 24.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 3.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.3 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 2.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 7.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.6 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.2 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 1.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 2.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |